Jameason Children's Hospital of Eastern Cameron

Dr. Jameason Children's Hospital of Eastern Cameron

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJameason Children's Hospital of Eastern Cameron
Jameason Children's Hospital of Eastern Cameron
GGGary S. Goldfield
Gary S. Goldfield
GFGraham Finlayson
Graham Finlayson
JBJohn E. Blundell
John E. Blundell
ÉDÉric Doucet
Éric Doucet
We examined the impact of a 24 hour complete fast (vs. fed state) on two measures of food reward: 1) ‘wanting’, as measured by response to food images and by the relative-reinforcing value of food (RRV), and 2) ‘liking’, as measured by response to food images and the hedonic evaluation of foods consumed. Utilizing a randomized crossover design, 15 subjects (9 male; 6 female) aged 28.6±4.5 yrs with body mass index 25.3±1.4 kg/m2 were randomized and counterbalanced to normal feeding (FED) and 24-hour fast (FASTED) conditions. Trait characteristics were measured with the Three Factor Eating Questionnaire. Two computer tasks measured food reward: 1) RRV progressive ratio task, 2) explicit ‘liking’ and ‘wanting’ (Leeds Food Preference Questionnaire, LFPQ). Also measured were ad libitum energy intake (EI; buffet) and food ‘liking’ (visual analogue scale) of personalized stimuli. There were no significant anthropometric changes between conditions. Appetite scores, hedonic ratings of ‘liking’, and ad libitum EI all significantly increased under the FASTED condition (p<0.05). Under the FASTED condition there were significant increases in the RRV of snack foods; similarly, explicit ‘wanting’ and ‘liking’ significantly increased for all food categories. ‘Liking’ of sweet foods remained high across-meals under FASTED, but savory foods decreased in hedonic saliency. Relative to a fed state, we observed an increase in hedonic ratings of food, the rewarding value of food, and food intake after a 24 hr fast. Alliesthesia to food and food cues is suggested by heightened hedonic ratings under the FASTED condition relative to FED.

13 April 2016 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
GGGary Goldfield
Gary Goldfield
MMMarisa Murray
Marisa Murray
DMDanijela Maras
Danijela Maras
AWAngela L. Wilson
Angela L. Wilson
PPPenny Phillips
Penny Phillips
RSRonald J. Sigal
Ronald J. Sigal

21 August 2017 in Annual Review of Nutrition
Verified
Journal Article
Closed access
JCJameason Children's Hospital of Eastern Cameron
Jameason Children's Hospital of Eastern Cameron
Jean-Philippe ChaputJean-Philippe Chaput
Jean-Philippe Chaput
ASAnders Mikael Sjödin
Anders Mikael Sjödin
GGGary Goldfield
Gary Goldfield
This review examines human feeding behavior in light of psychological motivational theory and highlights the importance of midbrain dopamine (DA). Prospective evidence of both reward surfeit and reward deficit pathways to increased body weight are evaluated, and we argue that it is more complex than an either/or scenario when examining DA's role in reward sensitivity, eating, and obesity. The Taq1A genotype is a common thread that ties the contrasting models of DA reward and obesity; this genotype related to striatal DA is not associated with obesity class per se but may nevertheless confer an increased risk of weight gain. We also critically examine the concept of so-called food addiction, and despite growing evidence, we argue that there is currently insufficient human data to warrant this diagnostic label. The surgical and pharmacological treatments of obesity are discussed, and evidence is presented for the selective use of DA-class drugs in obesity treatment.

1 April 2016 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
JCJameason Children's Hospital of Eastern Cameron
Jameason Children's Hospital of Eastern Cameron
GGGary S Goldfield
Gary S Goldfield
MRMarie-Ève Riou
Marie-Ève Riou
GFGraham S Finlayson
Graham S Finlayson
JBJohn E Blundell
John E Blundell
ÉDÉric Doucet
Éric Doucet
Background: Millions of Americans attempt to lose weight each year, and it is unclear whether the modality of acute, tightly controlled energy depletions can differently affect appetite parameters and olfaction.

15 April 2022 in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
Verified
Journal Article
Closed access
RVRégis Vaillancourt
Régis Vaillancourt
SGShannon Gallagher
Shannon Gallagher
JCJameason Children's Hospital of Eastern Cameron
Jameason Children's Hospital of Eastern Cameron
RDRahim Dhalla
Rahim Dhalla
Background: Medical cannabis has been increasingly used in Canada after being sanctioned by Health Canada in 2001. Insomnia and sleep disorders are among the most common conditions for which patients report using cannabis. Current research shows cannabis may have a beneficial effect in sleep disorders and may improve patient-reported sleep scores. Methods: A retrospective chart review was conducted at Hybrid Pharm community pharmacy in Ottawa, Ontario, and included patients who were interested in, or already using, medical cannabis for sleep disorders. A qualitative, exploratory approach was taken to evaluate the descriptive efficacy and safety of medical cannabis when prescribed for insomnia or comorbid conditions. The comprehensive data collection also involved investigating the impact of cannabis on other medication used for insomnia. Results: A total of 38 patients were identified as having adequate follow-up documentation to assess the impact of medical cannabis. At time of data collection, 15 patients (39%) were able to reduce or completely discontinue a prescription medication indicated for sleep. On follow-up, 27 patients (71%) reported a subjective improvement in their sleep or related condition. Only 8 patients (21%) reported any adverse effects from medical cannabis use, and these were manageable and did not require discontinuation of cannabis. Conclusion: This study highlights the importance of a pharmacist’s role in the management of cannabis-based therapy, including ongoing supportive care, follow-up and medication management. Can Pharm J (Ott) 2022;155:xx-xx.

30 September 2018 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
JWJeremy J. Walsh
Jeremy J. Walsh
ADAmedeo D'Angiulli
Amedeo D'Angiulli
JCJameason Children's Hospital of Eastern Cameron
Jameason Children's Hospital of Eastern Cameron
RSRonald J. Sigal
Ronald J. Sigal
GKGlen P. Kenny
Glen P. Kenny
GGGary Goldfield
Gary Goldfield
Obesity in youth increases the risk of type 2 diabetes (T2D), and both are risk factors for neurocognitive deficits. Exercise attenuates the risk of obesity and T2D while improving cognitive function. In adults, these benefits are associated with the actions of the brain-derived neurotrophic factor (BDNF), a protein critical in modulating neuroplasticity, glucose regulation, fat oxidation, and appetite regulation in adults. However, little research exists in youth. This study examined the associations between changes in diabetes risk factors and changes in BDNF levels after 6 months of exercise training in adolescents with obesity. The sample consisted of 202 postpubertal adolescents with obesity (70% females) aged 14–18 years who were randomized to 6 months of aerobic and/or resistance training or nonexercise control. All participants received a healthy eating plan designed to induce a 250/kcal deficit per day. Resting serum BDNF levels and diabetes risk factors, such as fasting glucose, insulin, homeostasis model assessment (HOMA-B—beta cell insulin secretory capacity) and (HOMA-IS—insulin sensitivity), and hemoglobin A1c (HbA1c), were measured after an overnight fast at baseline and 6 months. There were no significant intergroup differences on changes in BDNF or diabetes risk factors. In the exercise group, increases in BDNF were associated with reductions in fasting glucose (β = −6.57, SE = 3.37, p=0.05) and increases in HOMA-B (β = 0.093, SE = 0.03, p=0.004) after controlling for confounders. No associations were found between changes in diabetes risk factors and BDNF in controls. In conclusion, exercise-induced reductions in some diabetes risk factors were associated with increases in BDNF in adolescents with obesity, suggesting that exercise training may be an effective strategy to promote metabolic health and increases in BDNF, a protein favoring neuroplasticity. This trial is registered with ClinicalTrials.gov NCT00195858, September 12, 2005 (funded by the Canadian Institutes of Health Research).